Myriad Genetics Inc (MYGN) Stock Analysis

Sector: HEALTHCARE - DIAGNOSTICS & RESEARCH

Exchange: NASDAQ

Key Metrics

• Price: $4.86
• Market Cap: $445.56M
• EPS: $-4.35
• 52-Week High: $11.44
• 52-Week Low: $3.76

Market Sentiment

Myriad Genetics Inc currently has a Bullish sentiment score of 0.23.

About Myriad Genetics Inc

Myriad Genetics, Inc. is a prominent molecular diagnostics firm based in Salt Lake City, Utah, renowned for its innovative genetic testing solutions that support predictive, personalized, and prognostic medicine. The company specializes in key areas such as oncology, hereditary cancer, and reproductive health, empowering healthcare professionals to make data-driven decisions tailored to individual patients. With a strong focus on advancing genetic medicine, Myriad is dedicated to expanding it...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Myriad Genetics Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does MYGN pay dividends?

Myriad Genetics Inc (MYGN) does not currently pay a regular dividend.

What is MYGN's market cap?

Myriad Genetics Inc (MYGN) has a market capitalization of $445.56M with a current stock price of $4.86.